United States: Senate Help Committee Eyes Mental Health, Substance Use Package

This morning, the Senate HELP Committee will hold an executive session regarding the Mental Health Reform Act of 2016, a comprehensive mental health package negotiated in part by the Senate HELP Committee and the Administration. The HELP Committee will also follow up on the recently passed Comprehensive Addiction and Recovery Act (CARA) and consider four substance use bills as they relate to heroin and opioids. Given that two weeks of the legislative calendar were devoted to passing CARA, which was ultimately passed overwhelming by a vote of 94-1, it is hard to imagine these bills getting significant floor time. Still, that doesn't mean these bills would not be considered under unanimous consent, allowing members to pad their resume without wasting, for lack of a better word, precious legislative time prior to the 2016 elections. Before we take a closer look at mental health, let's consider the substance use legislation:

The Recovery Enhancement for Addiction Treatment (TREAT) Act (S. 1455): The TREAT Act would increase access to care by increasing the number of patients certain qualifying practitioners are initially allowed to treat from 30 to 100 patients per year. After one year, qualifying physicians would be permitted to request removal of the cap on the number of patients they can treat. A qualifying practitioner must either be a recognized substance abuse treatment specialist or complete an approved training in a qualified practice setting, as defined in the legislation. It also allows certain nurse practitioners, provided they are licensed in a state that already allows them to prescribe controlled substances, are supervised by a physician who is approved to prescribe opioid addiction medicine, and complete approved training on opioid addiction treatment, to treat up to 100 patients per year. Lastly, the Government Accountability Office would be required to examine changes in treatment availability and utilization, quality, and impact on state-level policies, among other metrics. This legislation was introduced by Senator Ed Markey (D-MA) and has 17 bipartisan cosponsors.

The Co-Prescribing Saves Lives Act of 2015 (S. 2256): This legislation would require HHS, DoD, and the VA to establish physician education and co-prescribing guidelines for federal health settings, which includes VA hospitals, DoD hospitals, Indian Health Service facilities, and federally-qualified health centers. It would also require the stated agencies to establish co-prescribing guidelines, as well as establish a four-year grant program to provide State departments of health with resources to develop and apply co-prescribing guidelines, and to provide for increased access to naloxone. The grant program would cost a total $2.5 million for each of fiscal years 2016 through 2020. This legislation was introduced by Senator Tim Kaine (D-VA) and is cosponsored by Senator Shelly Moore Capito (R-WV).

The National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2015 (S. 480): This legislation would reauthorize the NASPER program which provides grants to states to maintain, improve, and expand prescription drug monitoring programs. The grant program would allow states to maintain and operate existing state monitoring programs, require HHS to redistribute any funds that are returned among the grantees, require states to provide HHS with aggregate data and other information to support HHS evaluation of the success of programs, and to expand the program to include commonwealth territories. The grant program would cost $7 million for each of fiscal years 2016 through 2020. The legislation was introduced by Senator Jeanne Shaheen (D-NH) and has 11 bipartisan cosponsors.

The Plan of Safe Care Improvement Act: This legislation would amend the Child Abuse Prevention and Treatment Act (P.L. 93-247) to include policies and procedures regarding the development of a plan of safe care for an infant born and identified as being affected by illegal substance abuse or withdrawal symptoms. It would also require states to develop and implement monitoring systems to ensure the safety and well-being of children in order to address the health, including mental health, needs of the child and family involved. HHS would be required to ensure States are meeting federal requirements in improving the outcomes among children most at risk for child abuse and neglect. HHS would also be required to issue guidance regarding the requirements for the development and implementation of plans of safe care. This legislation has yet to be formally introduced and will be presented before the committee.

All these measures take steps to expand access to treatments as well as expand federal and state monitoring programs. Given the nature of this crisis, it makes sense that the Senate HELP Committee would join in the work already being done by the Judiciary and Finance committees to advance legislation to address the heroin and opioid epidemic. However, while members of both parties in the House of Representatives have devoted significant air time to talking about addressing opioids, the various committees have been short on holding hearings to advance legislation, which includes the recently passed CARA package. Whether the full Senate finds time to take up these measures following tomorrow's hearing will be telling of its prospects in the House of Representatives.

The same can be said for the Mental Health Reform Act of 2016, which has been endorsed by Senators Chris Murphy (D-CT) and Bill Cassidy (R-LA), who worked together in 2015 to introduce a similar mental health package. Senator Murphy did note that he intends to keep working with members of both parties to makes sure the bill is even stronger, which could mean this broad package is designed to bring people to the table with the hopes of getting more buy-in as they go, a similar approach taken by Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) in other legislation handled by the HELP Committee. Although, advocacy groups have expressed concern that the legislation would not be effective for those with mental illness, and Rep. Tim Murphy (R-PA-18), who authored a mental health overhaul currently stalled in the House, called it an abandoning of bipartisan House reforms.

What is important here, as noted by other advocacy groups, is that there is overwhelming support to do something around mental health reform. And while the Senate HELP version does something, there are several issues still hanging in the balance, including the IMD exclusion, which is as complicated as it is expensive. Additionally, if Majority Whip John Cornyn (R-TX) looks to include provisions from his Comprehensive Justice and Mental Health Act, namely provisions centered on gun control, it could send this entire package up in smoke. If this package advances out of committee and then passes on the Senate floor, it would give mental health reform new momentum in the House. While Rep. Tim Murphy stated, regarding the Senate bill, that "we can make a deal or we can make a difference," as the election draws near, there may be overwhelming pressure to take the former over the latter.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Rodney L. Whitlock
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.